Cargando…
Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247528/ https://www.ncbi.nlm.nih.gov/pubmed/33896795 http://dx.doi.org/10.2337/dc21-0256 |
| _version_ | 1783716540411019264 |
|---|---|
| author | Hamblin, Peter S. Wong, Rosemary Ekinci, Elif I. Sztal-Mazer, Shoshana Balachandran, Shananthan Frydman, Aviva Hanrahan, Timothy P. Hu, Raymond Ket, Shara N. Moss, Alan Ng, Mark Ragunathan, Sashikala Bach, Leon A. |
| author_facet | Hamblin, Peter S. Wong, Rosemary Ekinci, Elif I. Sztal-Mazer, Shoshana Balachandran, Shananthan Frydman, Aviva Hanrahan, Timothy P. Hu, Raymond Ket, Shara N. Moss, Alan Ng, Mark Ragunathan, Sashikala Bach, Leon A. |
| author_sort | Hamblin, Peter S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8247528 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82475282022-06-01 Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes Hamblin, Peter S. Wong, Rosemary Ekinci, Elif I. Sztal-Mazer, Shoshana Balachandran, Shananthan Frydman, Aviva Hanrahan, Timothy P. Hu, Raymond Ket, Shara N. Moss, Alan Ng, Mark Ragunathan, Sashikala Bach, Leon A. Diabetes Care e-Letters: Observations American Diabetes Association 2021-06 2021-04-25 /pmc/articles/PMC8247528/ /pubmed/33896795 http://dx.doi.org/10.2337/dc21-0256 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
| spellingShingle | e-Letters: Observations Hamblin, Peter S. Wong, Rosemary Ekinci, Elif I. Sztal-Mazer, Shoshana Balachandran, Shananthan Frydman, Aviva Hanrahan, Timothy P. Hu, Raymond Ket, Shara N. Moss, Alan Ng, Mark Ragunathan, Sashikala Bach, Leon A. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes |
| title | Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes |
| title_full | Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes |
| title_fullStr | Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes |
| title_full_unstemmed | Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes |
| title_short | Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes |
| title_sort | capillary ketone concentrations at the time of colonoscopy: a cross-sectional study with implications for sglt2 inhibitor–treated type 2 diabetes |
| topic | e-Letters: Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247528/ https://www.ncbi.nlm.nih.gov/pubmed/33896795 http://dx.doi.org/10.2337/dc21-0256 |
| work_keys_str_mv | AT hamblinpeters capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT wongrosemary capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT ekincielifi capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT sztalmazershoshana capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT balachandranshananthan capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT frydmanaviva capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT hanrahantimothyp capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT huraymond capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT ketsharan capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT mossalan capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT ngmark capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT ragunathansashikala capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes AT bachleona capillaryketoneconcentrationsatthetimeofcolonoscopyacrosssectionalstudywithimplicationsforsglt2inhibitortreatedtype2diabetes |